Annual report [Section 13 and 15(d), not S-K Item 405]

Note 16 - Income Taxes - Deferred Tax Assets and Liabilities (Details)

v3.25.1
Note 16 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Non-capital losses carried forward $ 32,240 $ 26,044
Research and development expenditures 817 817
Patents and other 400 358
Share-based compensation 284 212
Share issue costs 275 495
Accruals 256 214
Property and equipment (89) (102)
Total deferred tax asset, net 34,183 28,038
Valuation allowance (34,183) (28,038)
Net deferred tax asset $ 0 $ 0